Difference in the anti-proliferative effect by cholecalciferol between sublines of a pancreatic cancer cell lines and various genes expressions examined by cDNA array
胆钙化醇对胰腺癌细胞系亚系间抗增殖作用的差异及cDNA芯片检测各基因表达
基本信息
- 批准号:15591416
- 负责人:
- 金额:$ 1.92万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
To examine the difference in the anti-proliferative effect by cholecalciferol between pancreatic cancer cells by cholecalciferol, four sublines of a pancreatic cancer cell line SUIT-2,S2-007,S2-013,S2-020, and S2-028 were incubated at varied concentrations of cholecalciferol and the cellular proliferation were assessed by MIT assay. Messenger RNA levels of vitamin D receptor (VDR) were also measured by quantitative RT-PCT. As a result cholecalciferol inhibited the cellular proliferation depending on the concentrations (10^<-6> M,10^<-7> M,10^<-8> M), most strongly in S2-028, moderately in S2-007 and S2-013, and weekly in S2-002. Quantitative reverse transcriptase polymerase chain reaction showed higher constitutional gene expression of VDR mRNA in S-028 and greater induction by cholecalciferol than those in the other sublimes. To investigate the gene expressions, related to cellular proliferation and metastasis in these sublines, cDNA array analysis was performed in genes as follows : ACTB,AMFR,FGF2,CTSB,PECAM1,CD34,CDH1,EGFR,ETS1,FLT1,FLT4,FOS,KDR,MMP1,MMP2,MMP3,MMP7,MMP9,MET,MMP14,MMP16,MYC,RELA,NME1,NME2,SERPINE1,SERPINB2,TFRC,TGFA,TGFB1,TGFB2,TGFB3,TGFBR3,TIE,TEK,PLAU,PLAUR,VEGF,VEGFC,ITGA2,ITGA3,ITGA4,ITGA5,ITGA6,CTNNA1,ITGAV,THBS1,HTGB1,ITGB3,ITGB5,CTNNB1,AHCY,CBS,DNMT1,DNMT3A,HDAC1,HDAC2,HDAC3,HDAC4,HDAC5,HDAC6,MAT1A,MAT2A,MAT2B,MBD2,MBD3,MBD4,MECP2,MTHFR,MTR,CTSL,ANGPT2. As a result mRNA expression levels were higher than those of the other sublines in nine genes such as EGFR,MMP1,MMP3,MMP7,TGFB2,TGFBR3,PLAU,ITGA2, and ANGPT2. S2-028 showed higher gene expression than those in the other sublines.
为了检查胆钙化醇在胰腺癌细胞之间的胆钙化醇抗增殖作用的差异,将胰腺癌细胞系SUIT-2、S2-007、S2-013、S2-020和S2-028的四个亚系在不同浓度的胆钙化醇下孵育,并通过MIT测定评估细胞增殖。还通过定量RT-PCT测量维生素D受体(VDR)的信使RNA水平。因此,胆钙化醇根据浓度(10 μ <-6>M、10 μ <-7>M、10 μ <-8>M)抑制细胞增殖,在S2-028中最强,在S2-007和S2-013中中等,在S2-002中每周一次。定量逆转录聚合酶链反应显示,S-028中VDR mRNA的组成基因表达高于其他升华物,且胆钙化醇的诱导作用更强。为了研究这些亚系中与细胞增殖和转移相关的基因表达,在如下基因中进行cDNA阵列分析:ACTB、AMFR、FGF2、CTSB、PECAM 1、CD 34、CDH 1、EGFR、ETS1、FLT 1、FLT 4、FOS、KDR、MMP 1、MMP 2、MMP 3、MMP 7、MMP 9、MET、MMP 14、MMP 16、MYC、RELA、NME 1、NME 2、SERPINE1、SERPINB 2、TFRC、TGFA、TGFB1、TGFB2、TGFB3、TIE、TEK、PLAU、PLAUR、VEGF、VEGFC、ITGA 2、ITGA 3、ITGA 4、ITGA 5、ITGA 6、CTNNA 1、ITGV、THBS1、HTGB 1、ITGB 3、ITGB 5、CTNNB 1、AHCY、CBS、DNMT 1、DNMT 3A、HDAC 1、HDAC 2、HDAC 3、HDAC 4、HDAC 5、HDAC 6、MAT 1A、MAT 2A、MAT 2B、MBD2、MBD3、MBD4、MECP 2、MTHFR、MTR、CTSL、ANGPT 2。结果,EGFR、MMP 1、MMP 3、MMP 7、TGFB 2、TGFBR 3、PLAU、ITGA 2和ANGPT 2等9个基因的mRNA表达水平高于其他亚系。S2-028的基因表达量明显高于其它亚系。
项目成果
期刊论文数量(14)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Establishment and characterization of a novel human pancreatic cancer cell line (SUIT-4) metastasizing to lymph nodes and lungs in nude mice.
裸鼠淋巴结和肺转移的新型人胰腺癌细胞系(SUIT-4)的建立和表征。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Kawano;K.;et al.
- 通讯作者:et al.
Sum of the longest diameters of metastatic liver tumors is a possible new prognostic factor after hepatectomy in patients with colorectal liver metastases.
转移性肝肿瘤的最长直径总和可能是结直肠肝转移患者肝切除术后新的预后因素。
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Eto;T.-A.;Chijiiwa;K.et al.
- 通讯作者:K.et al.
Assay method for mitochondrial sterol 27-hydroxylase with 7α-hydroxy-4-cholesten-3-one as a substrate in the rat liver.
大鼠肝脏中以 7α-羟基-4-胆甾烯-3-酮为底物的线粒体甾醇 27-羟化酶的测定方法。
- DOI:
- 发表时间:2003
- 期刊:
- 影响因子:0
- 作者:Ota;Y;Eto;T.-A. et al.
- 通讯作者:T.-A. et al.
Assay method for mitochondrial sterol 27-hydroxylase with 7 α-hydroxy-4-cholesten-3-one as a substrate in the rat liver.
大鼠肝脏中以7α-羟基-4-胆甾烯-3-酮为底物的线粒体甾醇27-羟化酶的测定方法。
- DOI:
- 发表时间:2003
- 期刊:
- 影响因子:0
- 作者:Ota;Y;Eto;T.-A. et al.
- 通讯作者:T.-A. et al.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ETO Tadaaki其他文献
ETO Tadaaki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
重症下肢再灌流障害の研究--凍結保存虚血骨格筋MTT assayの確立--
严重下肢再灌注损伤的研究--冻存缺血骨骼肌MTT检测方法的建立--
- 批准号:
06671192 - 财政年份:1994
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
In vitro chemosensitivity by MTT assay and clinical outcomes in childhood leukemia
MTT 测定的体外化疗敏感性和儿童白血病的临床结果
- 批准号:
05670667 - 财政年份:1993
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Study of MTT Assay for Bone and Soft Tissue Tumor
骨与软组织肿瘤MTT检测研究
- 批准号:
01480365 - 财政年份:1989
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)